Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA
Go back to Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA| Baxter International Inc. (NYSE: BAX) | Delayed: 24.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.86 | 52 Week High | $50.16 | |||
| Open | $24.86 | 52 Week Low | $34.06 | |||
| Day High | $24.86 | P/E | 6.79 | |||
| Day Low | $24.86 | EPS | $3.66 | |||
| Volume | 122 | |||||
| (NASDAQ: NUWE) | Delayed: 0.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.79 | 52 Week High | $ | |||
| Open | $0.79 | 52 Week Low | $ | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.79 | EPS | $ | |||
| Volume | 1,559 | |||||
